feed,title,long_url,short_url
Benzinga,"One Year Following Single Administration, UniQure's Hemophilia B Gene Therapy Candidate Shows Sustained Increase In Factor IX Levels",https://benzinga.com/general/biotech/21/06/21670303/one-year-following-single-administration-uniqures-hemophilia-b-gene-therapy-candidate-shows-susta,https://j.mp/3zOlRAE
Benzinga,Pear Therapeutics Plans To Go Public In $1.6B SPAC Deal,https://benzinga.com/general/biotech/21/06/21671276/pear-therapeutics-plans-to-go-public-in-1-6b-spac-deal,https://j.mp/3vY3yGd
